Cargando…

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

IMPORTANCE: Patients with nonmetastatic nasopharyngeal carcinoma (NPC) are primarily treated by radiotherapy with curative intent with or without chemotherapy and often experience substantial treatment-related toxic effects even with modern radiation techniques, such as intensity-modulated radiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xingzhe, Kitpanit, Sarin, Lee, Anna, Mah, Dennis, Sine, Kevin, Sherman, Eric J., Dunn, Lara A., Michel, Loren S., Fetten, James, Zakeri, Kaveh, Yu, Yao, Chen, Linda, Kang, Jung Julie, Gelblum, Daphna Y., McBride, Sean M., Tsai, Chiaojung J., Riaz, Nadeem, Lee, Nancy Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214161/ https://www.ncbi.nlm.nih.gov/pubmed/34143193 http://dx.doi.org/10.1001/jamanetworkopen.2021.13205

Ejemplares similares

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Youssef, Irini, et al.
Publicado: (2022)

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base
por: Kitpanit, Sarin, et al.
Publicado: (2020)

Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma
por: Lee, Anna, et al.
Publicado: (2023)

Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer
por: Oonsiri, Sornjarod, et al.
Publicado: (2022)

Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue
por: Press, Robert H, et al.
Publicado: (2023)

Prognostic Value of Plasma EBV DNA for Nasopharyngeal Cancer Patients during Treatment with Intensity-modulated Radiation Therapy and Concurrent Chemotherapy
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018)

Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology
por: Hesse, Jennifer, et al.
Publicado: (2022)

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2022)

Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018)

Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy
por: Yang, Fan, et al.
Publicado: (2023)

Intensity modulated radiation therapy versus volumetric intensity modulated arc therapy
por: Rana, Suresh
Publicado: (2013)

Intensity-Modulated Radiation Therapy
por: Webb, S
Publicado: (2001)

Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients
por: Yoon, Han Gyul, et al.
Publicado: (2021)

Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer
por: Smith, Grace L., et al.
Publicado: (2021)

Comparison of 3D Conformal Proton Therapy, Intensity-Modulated Proton Therapy, and Intensity-Modulated Photon Therapy for Retroperitoneal Sarcoma
por: Chung, Christine, et al.
Publicado: (2022)

A Dosimetric Comparison of Intensity-Modulated Proton Therapy, Volumetric-Modulated Arc Therapy, and 4π Non-Coplanar Intensity-Modulated Radiation Therapy for a Patient with Parameningeal Rhabdomyosarcoma
por: Chen, Tiffany W, et al.
Publicado: (2017)

A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer
por: Lee, Anna, et al.
Publicado: (2021)

Assessment of the modulation degrees of intensity-modulated radiation therapy plans
por: Park, So-Yeon, et al.
Publicado: (2018)

Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy
por: Chi, Alexander, et al.
Publicado: (2017)

Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study
por: White, Peter, et al.
Publicado: (2013)

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma
por: Yu, Nathan Y, et al.
Publicado: (2019)

Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
por: Aizawa, Rihito, et al.
Publicado: (2019)

Validation of Delivery Consistency for Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy Plans
por: Woon, Wui Ann, et al.
Publicado: (2018)

Intensity modulated radiation therapy for head and neck cancer /
Publicado: (2003)

Preoperative Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma
por: El-Bared, Nancy, et al.
Publicado: (2014)

Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer
por: Ashamalla, Hani, et al.
Publicado: (2013)

Useful island block geometries of a passive intensity modulator used for intensity‐modulated bolus electron conformal therapy
por: Chambers, Erin L., et al.
Publicado: (2020)

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data
por: Weg, Emily S., et al.
Publicado: (2019)

Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?
por: Chan, Tabitha Y, et al.
Publicado: (2017)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Intensity-modulated radiation therapy: emerging cancer treatment technology
por: Hong, T S, et al.
Publicado: (2005)

Tangential intensity modulated radiation therapy (IMRT) to the intact breast
por: Dean, Jenna, et al.
Publicado: (2016)

Application of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma
por: Yan, Hao, et al.
Publicado: (2017)

Intensity modulated radiation therapy for breast cancer: current perspectives
por: Buwenge, Milly, et al.
Publicado: (2017)

Reimbursement and use of intensity-modulated radiation therapy for prostate cancer
por: Shahinian, Vahakn B., et al.
Publicado: (2017)

Recent trends in intensity-modulated radiation therapy use in Korea
por: Huh, Seung Jae, et al.
Publicado: (2019)

Planning and delivery of intensity modulated bolus electron conformal therapy
por: Hilliard, Elizabeth N., et al.
Publicado: (2021)

Worsening Racial Disparities in Utilization of Intensity Modulated Radiation Therapy
por: Hutten, Ryan J., et al.
Publicado: (2022)

Skin Sparing in Intensity-Modulated Radiation Therapy of Nasopharyngeal Carcinoma
por: Baba, Misba Hamid, et al.
Publicado: (2022)

Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison
por: Wang, Lei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tidsnkuc22ebc5bsq5pdehnrl2